DHG Pharmaceutical JSCSTC:DHG 80 PEG Ratio is 3.08 as of Jul. 01, 2026, which is 14% above its 10-year median of 2.70. GuruFocus rates STC:DHG with a GF Score™ of 80/100 and a GF Value™ of ₫113,504.89 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 349 Drug Manufacturers companies, DHG Pharmaceutical JSC ranks worse than 68.77% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for DHG Pharmaceutical JSC's PEG Ratio or its related term are showing as below:
STC:DHG'
s PEG Ratio Range Over the Past 10 Years
Min: 0.78 Med: 2.7 Max: 166.79
Current: 3.08
During the past 13 years, DHG Pharmaceutical JSC's highest PEG Ratio was 166.79. The lowest was 0.78. And the median was 2.70.
STC:DHG's PEG Ratio is ranked worse than 68.77% of 349
companies
in the Drug Manufacturers industry
Industry Median: 1.69
vs STC:DHG: 3.08
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
DHG Pharmaceutical JSC (STC:DHG) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, DHG Pharmaceutical JSC's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DHG Pharmaceutical JSC PEG Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, DHG Pharmaceutical JSC's PEG Ratio distribution charts can be found below:
* The bar in red indicates where DHG Pharmaceutical JSC's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
DHG Pharmaceutical JSC (STC:DHG) has a PEG Ratio of 3.08 as of Jul. 01, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on DHG Pharmaceutical JSC and its competitors. This is 14% above median its historical median of 2.70. Over the past decade, DHG Pharmaceutical JSC's PEG Ratio has ranged from 0.78 to 166.79. According to the industry distribution chart, DHG Pharmaceutical JSC ranks #240 out of 349 companies in the Drug Manufacturers industry, placing it in the top 68.8%.
Is DHG Pharmaceutical JSC's PEG Ratio too high?
DHG Pharmaceutical JSC's current PEG Ratio of 3.08 is 14% above median its 10-year median of 2.70. Over the past 10 years, this metric has ranged from a low of 0.78 to a high of 166.79. The Drug Manufacturers industry median PEG Ratio is 1.69. DHG Pharmaceutical JSC's value of 3.08 is 82.2% above this industry median. Based on the distribution chart, DHG Pharmaceutical JSC ranks #240 out of 349 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, DHG Pharmaceutical JSC has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DHG Pharmaceutical JSC's PEG Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, DHG Pharmaceutical JSC ranks #240 out of 349 companies for PEG Ratio. This places DHG Pharmaceutical JSC in the lower half of its industry. The industry median PEG Ratio is 1.69. DHG Pharmaceutical JSC's value of 3.08 is 82.2% above this benchmark. Historically, DHG Pharmaceutical JSC's own PEG Ratio has ranged from 0.78 to 166.79 over the past decade. While the company's 10-year median is 2.70 vs. the industry median of 1.69, DHG Pharmaceutical JSC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Drug Manufacturers company?
The median PEG Ratio among Drug Manufacturers companies is 1.69, based on 349 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DHG Pharmaceutical JSC's current PEG Ratio of 3.08 is 82.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on DHG Pharmaceutical JSC and its competitors. For the Drug Manufacturers industry, the median PEG Ratio is 1.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DHG Pharmaceutical JSC's current PEG Ratio is 3.08, which is 14% above median its own 10-year median of 2.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DHG Pharmaceutical JSC stock overvalued right now?
Based on GuruFocus' analysis, DHG Pharmaceutical JSC (STC:DHG) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫113,504.89, compared to a current price of ₫93,200.00 — trading 17.9% below its estimated fair value. The current PEG Ratio is 3.08, which is 14% above median its 10-year median of 2.70 and 82.2% above the Drug Manufacturers industry median of 1.69. DHG Pharmaceutical JSC's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For DHG Pharmaceutical JSC (STC:DHG), the current PEG Ratio is 3.08 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DHG Pharmaceutical JSC (STC:DHG) Overvalued in 2026?
Based on GuruFocus' analysis, DHG Pharmaceutical JSC stock appears to be undervalued.
The current stock price of ₫93,200.00 is trading 17.9% below its estimated GF Value™ of ₫113,504.89.
GuruFocus considers DHG Pharmaceutical JSC to be Modestly Undervalued.
Key valuation signals for STC:DHG:
PEG Ratio: 3.08 (14% above median its 10-year median of 2.70)
GF Value™: ₫113,504.89 vs. price of ₫93,200.00 (17.9% below fair value)
Industry Position: 82.2% above the Drug Manufacturers median (#240 of 349)
No single metric tells the full story. See the STC:DHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DHG Pharmaceutical JSC produces and trades in pharmaceutical products. It provides various pharmaceutical products in the areas of antibiotics, antifungals, and antiparasitics; analgesics and antipyretics; ear-nose-throat, cough, and asthma; ophthalmic and nervous system; muscular and osteoarticular; digestive; hepatic; cardiovascular and diabetic; vitamins and minerals; and dermal and beauty care.
80GF Score
Get the complete analysis for STC:DHG
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STC:DHG has been successfully added to your 
